<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://neuropinc.com/wp-sitemap.xsl" ?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"><url><loc>https://neuropinc.com/neurop-and-emory-scientists-target-cognitive-and-mental-health-disorders/</loc><lastmod>2013-02-19T01:36:20+00:00</lastmod></url><url><loc>https://neuropinc.com/neurop-receives-second-half-of-nih-grant-for-meeting-schizophrenia-research-milestones/</loc><lastmod>2013-04-15T01:37:16+00:00</lastmod></url><url><loc>https://neuropinc.com/neurop-receives-third-year-of-nih-funding-for-ischemia-research/</loc><lastmod>2014-04-11T01:38:35+00:00</lastmod></url><url><loc>https://neuropinc.com/neurop-selects-np10679-as-development-candidate-for-sah/</loc><lastmod>2014-05-21T01:47:34+00:00</lastmod></url><url><loc>https://neuropinc.com/lee-h-latimer-joins-neurop-to-manage-its-chemistry-operations/</loc><lastmod>2014-08-11T01:49:18+00:00</lastmod></url><url><loc>https://neuropinc.com/neurop-awarded-nih-grant-for-alzheimers-disease-drug-research/</loc><lastmod>2014-09-29T01:51:53+00:00</lastmod></url><url><loc>https://neuropinc.com/neurop-receives-milestone-payment-as-bristol-myers-squibb-nominates-nmda-receptor-compound-as-drug-development-candidate/</loc><lastmod>2014-10-02T02:02:43+00:00</lastmod></url><url><loc>https://neuropinc.com/neurop-announces-strategic-collaboration-with-johnson-johnson-innovation-to-study-role-of-nmda-receptors/</loc><lastmod>2015-04-27T02:04:17+00:00</lastmod></url><url><loc>https://neuropinc.com/life-sciences-summit-new-york-city-dec-2015/</loc><lastmod>2015-09-12T20:45:41+00:00</lastmod></url><url><loc>https://neuropinc.com/neurops-lee-latimer-elected-to-acs-2016-board-of-directors/</loc><lastmod>2015-11-09T23:54:14+00:00</lastmod></url><url><loc>https://neuropinc.com/biotech-showcase-2016-san-francisco/</loc><lastmod>2015-11-30T22:47:22+00:00</lastmod></url><url><loc>https://neuropinc.com/nih-awards-neurop-3-5-million-to-support-phase-1-clinical-trial-of-nmda-inhibitor-np10679/</loc><lastmod>2017-07-24T13:07:49+00:00</lastmod></url><url><loc>https://neuropinc.com/neurop-selected-to-compete-in-innovation-challenge-at-resi-2017/</loc><lastmod>2017-09-01T20:34:04+00:00</lastmod></url><url><loc>https://neuropinc.com/neurop-initiates-phase-1-clinical-trial-of-nmda-receptor-inhibitor-np10679/</loc><lastmod>2018-04-12T13:28:16+00:00</lastmod></url><url><loc>https://neuropinc.com/neurop-announces-positive-topline-data-from-phase-1-studies-for-lead-candidate-np10679-for-cns-disorders/</loc><lastmod>2020-05-28T12:20:00+00:00</lastmod></url><url><loc>https://neuropinc.com/neurop-receives-fda-orphan-drug-designation-for-np10679-for-sah/</loc><lastmod>2021-12-08T14:08:55+00:00</lastmod></url><url><loc>https://neuropinc.com/neurop-signs-option-agreement-with-seyltx/</loc><lastmod>2025-08-09T15:16:45+00:00</lastmod></url><url><loc>https://neuropinc.com/neurop-honored-at-georgia-life-sciences-summit/</loc><lastmod>2024-09-09T15:16:55+00:00</lastmod></url></urlset>
